The site offers oligonucleotide and peptide discovery synthesis from library screening to preclinical candidates’ selection. It also provides pre-formulation and formulation development for both oral and injectable dosage forms. The analytical teams support drug product from preclinical to commercial manufacturing. Additionally, the team offers lipid nanoparticle formulation development for oligonucleotide drugs.
Our Waigaoqiao site has successfully passed numerous inspections by the US FDA, China NMPA, Japan PMDA, and South Korea MFDS.
